In vivo colonization by different Lactobacilus strains on human intestinal mucosa of healthy volunteers was studied together with the effect of Lactobacilus administration on different groups of indigenous bacteria. A total of 19 test strains were administered in fermented oatmeal soup containing 5 x 106 CFU of each strain per ml by using a dose of 100 ml of soup per day for 10 days. Biopsies were taken from both the upper jejunum and the rectum 1 day before administration was started and 1 and 11 days after administration was terminated.
In vivo colonization by different Lactobacilus strains on human intestinal mucosa of healthy volunteers was studied together with the effect of Lactobacilus administration on different groups of indigenous bacteria. A total of 19 test strains were administered in fermented oatmeal soup containing 5 x 106 CFU of each strain per ml by using a dose of 100 ml of soup per day for 10 days. Biopsies were taken from both the upper jejunum and the rectum 1 day before administration was started and 1 and 11 days after administration was terminated.
The administration significantly increased the LactobaciUus counts on the jejunum mucosa, and high levels remained 11 days after administration was terminated. The levels of streptococci increased by 10-to 100-fold in two persons, and the levels of sulfite-reducing clostridia in the jejunum decreased by 10-to 100-fold in three of the volunteers 1 day after administration was terminated. In recta, the anaerobic bacterium counts and the gram-negative anaerobic bacterium counts decreased significantly by the end of administration. Furthermore, a decrease in the number of members of the Enterobacteriaceae by 1,000-fold was observed on the rectal mucosa of two persons. Randomly picked Lactobacillus isolates were identified phenotypically by API 5OCH tests and genotypically by the plasmid profiles of strains and by restriction endonuclease analysis of chromosomal DNAs.
The following five administered Lactobacilus strains were reisolated from the mucosa 1 day after the end of administration: LactobaciUus plantarum 299 and 299v, LactobaciUus casei subsp. rhamnosus 271, Lactobacilus reuteri 108, and LactobaciUlus agilis 294. All of these strains were also found 11 days after administration was terminated, although L. plantarum 299 and 299v were dominant.
Enteral nutrition has several advantages over total parenteral nutrition. It is simpler to administer and cost effective, and since it maintains intestinal function and structure, it reduces treatment-related morbidity compared with total parenteral nutrition (2, 19, 38) . The nutritional formula of an enteral feeding product is crucial, and oats are known to have a favorable nutrient content, comprising high levels of polyunsaturated fatty acids, phospholipids, high-quality protein, and fibers as beta-glucans; oats also contain many minerals and vitamins (12, 37) . A new oatmeal-based product for enteral feeding has been developed recently (26) . Oatmeal is mixed with water, supplemented with an enzyme mixture, heated, and then cooled and fermented with Lactobacillus spp. The product not only has an advantageous nutritional composition but also contains high numbers of viable lactobacilli.
Members of the genus Lactobacillus make up an integral part of the healthy human intestinal flora. By producing vitamins and enzymes, Lactobacillus spp. can affect the metabolism of a host (8, 16) , and by producing antimicrobial compounds, lactobacilli may provide therapeutic benefits by controlling the proliferation of undesired pathogens (4, 7, 11, 13) . Antibiotic therapy can disturb the indigenous intestinal flora, resulting in a significant decrease in Lactobacillus spp. (3, 20, 21) , which is a common problem in treatment of infectious diseases and postoperative septic complications (17) . A patient with a suppressed indigenous flora is more susceptible to secondary infections and overgrowth of undesired microorganisms, leading to diarrhea and even * Corresponding author. pseudomembraneous colitis and development of distant organ failure (5, 17, 22) . Administration of Lactobacillus spp. to restore the indigenous human intestinal flora in cases of diarrhea has been tried in several studies, mostly with positive results (14, 21, 35, 40) .
A starter culture suited for fermented oatmeal soup not only should be beneficial for the product per se, but also should be able to colonize the intestinal tract and to compete with the resident flora. Thus, the bacteria should be able to survive the low pH values of the stomach and to tolerate the bile salts in the duodenum. Furthermore, many factors, such as adhering capacity, growth rate, and antimicrobial activity, may be important for establishment on the intestinal mucous membrane (4, 31 (24) . One strain originated from rat intestinal mucosa (23, 25) , and one strain originated from sour dough. weeks after the end of administration). An 18.4-g portion of freeze-dried fermented oatmeal soup was mixed with cold water to make a final volume of 100 ml, and this preparation was ingested once a day for 10 days. The daily intake was about 5 x 108 CFU of each test strain.
This study was approved by the Ethics Committee for Human Studies at Lund University.
Sampling. Samples were taken as biopsies at the following times: (i) before the administration of fermented oat meal soup, (ii) 1 day after the end of administration, and (iii) 11 days after the end of administration. The samples were removed from the rectum by rectoscopy and from the upper jejunum just distal to the ligament of Treitz by using a Watson intestinal biopsy capsule (Ferraris Development and Engineering Co., Ltd., Edmonton, London, England). The biopsy samples were gently washed with a sterile 0.9% NaCl solution, immediately put into transport medium (0.9% NaCl, 0.1% peptone, 0.1% Tween 80, 0.02% cysteine), kept cold, and delivered to the laboratory for microbiological examination. They were then weighed (average weight, 0.05 ± 0.005 g), treated in an ultrasonic bath for 5 min, and vortexed for 2 min before dilution and inoculation onto selective media.
Viable counts were obtained from brain heart infusion agar (Difco) that was incubated aerobically and anaerobically at 37°C for 3 days (aerobic and anaerobic bacterial counts, respectively), from Rogosa agar (Difco) that was incubated anaerobically at 37°C for 5 days (Lactobacillus counts), from MRS agar at pH 5.5 (Oxoid) that was incubated anaerobically at 37°C for 5 days (lactic acid bacterial counts), from phenylethanol agar (Difco) that was incubated aerobically and anaerobically at 37°C for 3 days (grampositive bacterial counts), from azide blood agar (Oxoid) that was incubated aerobically and anaerobically at 37°C for 3 days (mainly streptococcal counts), from Slanetz-Bartley agar (Oxoid) that was incubated aerobically at 37°C for 2 days (Enterococcus counts), from tryptose-sulfite-cycloserine agar (perfringens agar base [Oxoid] containing 4% cycloserine [Sigma] ) that was incubated anaerobically at 37°C for 3 days (sulfite-reducing clostridial counts), from violet red-bile-glucose agar (Oxoid) that was incubated aerobically at 37°C for 1 day (Enterobactenaceae counts), and from brain heart infusion agar containing a gram-negative anaerobic supplement (Oxoid) that was incubated anaerobically at 37°C for 3 days (gram-negative anaerobic bacterial counts). The Gaspak system (BBL Microbiology Systems, Cockeysville, Md.) was used for the anaerobic incubations.
Statistical evaluation. A statistical evaluation of the significance of the differences in the numbers of bacteria obtained at the three sampling times was performed by using the Kruskal-Wallis test and the Wilcoxon signed rank test.
Isolation and identification. For each biopsy, 10 Lactobacillus colonies were isolated randomly from the countable Rogosa plates. Each isolate was purified on Rogosa agar, suspended in freezing buffer (1) , and stored at -80°C. The isolates were tentatively identified by using the API 50CH system. These identifications were confirmed by analyzing the plasmid profiles (6) and by restriction endonuclease analysis of chromosomal DNAs (36) than 30% among the test strains except for strains LP 299 and LP 299v, which differed in only one band (Fig. 1) . It was extremely difficult to prepare DNA from some isolates, and therefore, the soluble protein contents of these organisms were studied as described below. A 0.1-g portion of cells from an overnight culture was mixed with 0. Tables 2 and 3 . In the upper jejunum the number of Lactobacillus counts increased significantly during administration; the high levels remained 11 days after the end of administration.
No other significant changes were observed in the jejunum. However, during the period of administration, the levels of aerobic streptococci increased in the jejuna of two persons by at least 10-to 100-fold, while the levels of sulfite-reducing clostridia in jejuna decreased by 10-to 100-fold in three persons. These changes were observed 11 days after the end of administration (Table 2 and data not shown).
On the rectal mucosa a slight, but not significant increase in the number of lactobacilli was observed both 1 and 11 days after administration ended. Significant decreases in anaerobic bacterial counts and in gram-negative anaerobic bacterial counts were detected both 1 and 11 days after administration ended.
In two persons, the levels of members of the Enterobacteriaceae on the rectal mucosa decreased by at least 1,000-fold during the period of administration. The levels then increased slightly 11 days after the end of administration (Table 3 and data not shown).
Colonization. (i) Phenotypic identification. The ability of the 19 administered Lactobacillus strains to colonize the intestinal mucosa of healthy volunteers was evaluated phenotypically (Table 4) . Before administration, two of the volunteers were colonized with strains having the same phenotype (identical API 50CH patterns) as strain LCR 271, and three volunteers harbored strains identical to strain LA 294. None of these phenotypes was observed in these persons 11 days after the end of administration (Table 4) .
At 1 day after the end of administration, 5 of the 19 test strains were identified phenotypically from mucosal samples (strains LP 299, LP 299v, LCR 271, LR 108 and LA 294). Strains having the same phenotypes were also isolated from the intestinal mucosa 11 days after the end of administration; However, strains LP 299 and LP 299v were now dominating (Table 4) .
(ii) Genotypic identification. The phenotypic identification of isolates sampled 11 c The values in brackets are the numbers of volunteers for whom the bacterial counts were below the limit of detection.
d Limit of detection, 1,000 CFU/g of mucosa. e Limit of detection, 100 CFU/g of mucosa. f P < 0.01 compared with the value before administration.
g-, all values were below the limit of detection (1,000 CFU/g of mucosa).
299 and LP 299v exhibited the same plasmid profile contain-DNA was extremely difficult to prepare from the isolates ing four plasmids (4.2, 9.1, 20, and 35 MDa). The cleavage identified as strain LA 294. However, the protein profiles of patterns of chromosomal DNAs obtained by digestion with these organisms were identical to the protein profile of strain EcoRI differed only in one band (Fig. 1) .
LA 294, and they were therefore identified as strain LA 294. Three volunteers harbored isolates having a phenotype identical to that of strain LCR 271. However, the presence of DISCUSSION strain LCR 271 was confirmed genetically in only one of the volunteers. Both the plasmid profiles and the restriction Oral administration of Lactobacillus strains has been endonuclease patterns of the isolates from the other two shown to increase the levels of lactobacilli in human feces persons differed slightly from those of strain LCR 271. (22, 33) . b The values in parentheses are ranges. c P < 0.01 compared with the value before administration. d The values in brackets are the numbers of volunteers for whom the bacterial counts were below the limit of detection. It has also been shown by other workers that Lactobacillus administration can decrease the numbers of fecal Escherichia coli and anaerobic cocci (22) . In our study, the levels of members of the Enterobacteriaceae on the rectal mucosa were decreased in some volunteers, but not in all volunteers. However, the anaerobic bacterial counts and the counts of gram-negative anaerobic bacteria were significantly decreased on the mucosa of recta, and this was especially pronounced 11 days after the end of administration. This suggests that after a period of establishment, the lactobacilli, exercise an antagonistic effect against the anaerobic flora. From a medical perspective, this must be regarded as advantageous. Several studies have shown that gram-negative anaerobic bacteria are frequently isolated from infected sites in patients with postoperative intraabdominal septic complications (28, 30, 39) .
Previous administration studies have been performed with Lactobacillus acidophilus NCDO 1748 (22) and Lactobacillus casei GG (33) . In the former study, volunteers were given about 3 x 1011 CFU per day for 7 days, but increases in the numbers of L. acidophilus were observed only as long as the participants were consuming the preparation. In the latter study, it was shown that L. casei GG must be given in doses of about 109 to 1010 CFU per day to be detectable in feces during the administration period. The volunteers in our study were given about 5 x 108 CFU of each test strain per day, although we were able to show that five of the strains colonized the intestinal mucosa and remained there for at least 11 days after administration ended.
L. acidophilus is often referred to as the most typical Lactobacillus species in gastrointestinal tracts (18, 27) . However, in our study, none of the L. acidophilus-like test strains was reisolated from the mucosa. Instead, the two Lactobacillus plantarum strains seemed to be superior. Strain LP 299v, which originated from sour dough, was surprisingly dominant. The other strain, strain LP 299, which was of human intestinal origin, would be expected to be the strain that is best adapted to the intestinal environment. However, we do not know the reason for the colonization, and the two strains were closely related. Phenotypically, they were identical, and only minor differences were observed in their chromosomal DNAs in the restriction endonuclease analysis (Fig. 1) .
The L. casei subsp. rhamnosus test strain, strain LCR 271, was observed in one person 11 days after the end of administration. In addition, phenotypically identical isolates were found in two other volunteers. However, these organisms differed genetically from strain LCR 271. This demonstrates why it is necessary to use genetic identification methods in colonization studies.
The following two Lactobacillus reuteri strains were administered in this study: strain LR 108, which was of human intestinal origin, and strain LR 47, which originated from rat intestinal mucosa. Strain LR 108 was reisolated from the intestinal mucosa of three volunteers 11 days after the end of administration, while strain LR 47 was never found. However, in a previous study (23) , it was shown that strain LR 47 had an outstanding colonization capacity in rat intestines, while strain LR 108 could not colonize at all. This clearly shows that a certain Lactobacillus strain with an excellent colonization capacity in one species is not necessarily a good colonizer in another species.
Our results show that the genus Lactobacillus is one of the dominant genera in the jejunum. It could be argued that the bacterial concentrations in the mucosa of jejuna are relatively low and that the bacteria present are only temporary contaminants from the upper respiratory tract. However, more permanent establishment is indicated by the facts that (i) the test organisms were detected 11 days after the end of administration, and (ii) test strains found on the mucosa of jejuna were also found in recta.
In conclusion, we proved that certain Lactobacillus strains have a general ability to colonize human intestinal mucosa, independent of dietary and physiological differences among individuals. There is still a question to be answered: do these colonizing lactobacilli have any beneficial effects on the host?
It has been shown recently that strain LR 47, which exhibik a pronounced colonizing ability in rats, also has the ability to reduce the incidence of bacteremia in rats after experimental intraabdominal infection (29) and the ability to hinder acetic acid-induced colitis (10) . 
